Studies show that GLP-1s can lower blood pressure, improve fatty liver disease, and even drastically reduce the progression of kidney disease and the risk of heart attacks and strokes
"That variability in sourcing is one of the biggest concerns, particularly when it comes to purity, dosing consistency and overall quality control." The FDA does not allow production of BPC-157, GHK-Cu, KPV and ipamorelin in the U.S., for example, by compounding pharmacies because of safety concerns , so people are ordering them from overseas usually from China
Researchers evaluated 0.5 mg, 1.0 mg, and higher doses, assessing glycemic efficacy measured by HbA1c reduction alongside safety parameters
Green tea contains polyphenols and catechols, which have excellent antioxidant qualities
Gallup found that one-third of people currently taking compounded GLP-1s said they came from an FDA-approved medication, while just 10% made the switch the other way
Angiology 26 , 474487 (1975)